Holen Sie sich die Stockscreener-App
186.11
0.94%
0.72
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
How Charles River’s Expanded Rat IVF Platform Could Reshape CRL’s Preclinical Services Mix and Investor View - Sahm
MSN Money - MSN
What you need to know ahead of Charles River Laboratories' earnings release - MSN
Charles River (NYSE: CRL) CFO receives 21,112-share stock award - Stock Titan
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight - GlobeNewswire Inc.
Charles River Gears Up for Q1 Earnings: What's in the Cards? - Yahoo Finance
Charles River Laboratories (CRL) Stock Report: Analyst Consensus and 20% Upside Potential - DirectorsTalk Interviews
LaPlume buys Charles River Labs [CRL] shares worth $4363 - Investing.com
Charles River Laboratories stock: Is CRL underperforming the healthcare sector? - MSN
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Vanguard Group Inc. Purchases 47,432 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
A Look At Charles River Laboratories (CRL) Valuation After Recent Share Weakness And Diverging Fair Value Views - simplywall.st
CRL Stock Price, Quote & Chart | CHARLES RIVER LABORATORIES (NYSE:CRL) - ChartMill
Charles River (CRL) Introduces New In Vitro Fertility Service Bu - GuruFocus
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
First commercial rat IVF service targets breeding bottlenecks - Stock Titan
Pekin Hardy Strauss Inc. Lowers Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories Stock: Q1 2026 Earnings Release Scheduled for April 30 - AD HOC NEWS
Charles River Laboratories International (CRL) Projected to Post Earnings on Thursday - MarketBeat
Charles River gains new outperform at RBC despite NAMs related disruption - MSN
Vanguard (NYSE: CRL) reports 7.38% ownership of Charles River shares - Stock Titan
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Here's why Charles River Laboratories (CRL) is a strong value stock - MSN
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Charles River appoints Birgit Girshick as incoming CEO as long-serving chief prepares to step down - MSN
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock - Yahoo Finance
Charles River Laboratories appoints Birgit Girshick as CEO following James Foster's retirement - MSN
Why is Charles River (CRL) down 6.8% since last earnings report? - MSN
Charles River announces divestitures, updates guidance - MSN
CROs fall as FDA head Makary says drug approvals will require fewer trials - MSN
M&T Bank Corp Grows Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
0.07%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):